+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Inhalation anesthetics Market 2019-2025

  • PDF Icon

    Report

  • May 2020
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 5129705
Global Inhalation anesthetics Market Size, Share & Trends Analysis Report by Surgery Type (Sevoflurane, Isoflurane, Desflurane, Nitrous Oxide, and Other), by Application (Induction, Maintenance) by End-User (Hospitals, Ambulatory Surgical Centers, and Other) Forecast Period (2019-2025)
The inhalation anesthetics market is anticipated to showcase a significant growth rate during the forecast period. The growing geriatric population, rising number of surgeries across the globe, and increase in the per capita healthcare expenditure are the key factors that are promoting the growth of the inhalation anesthetics market across the globe. However, the presence of different side effects associated with the usage of inhalation anesthetics is anticipated to restrict the growth of this global market.

The inhalation anesthetics market is segmented on the basis of product type, and application. Based on product type, the market is segmented into sevoflurane, isoflurane, desflurane, nitrous oxide, and others. Sevoflurane is anticipated to hold considerable market share during the forecast period. Low cost and high effectiveness of these drugs are the major factors to drive the growth of this market segment. Based on application the market is segmented into induction and maintenance. Based on the end-user, the market is segmented into hospitals, ambulatory surgical centers, and other end-users.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is anticipated to hold a considerable share in the inhalation anesthetics market. The presence of major players, such as AbbVie Inc., Halocarbon Products Corp., Lunan Pharmaceuticals Group Co. Ltd. is a major factor contributing towards the high market share of the region. However, Asia-Pacific is anticipated to exhibit a modest CAGR during the forecast period. The increasing number of surgical procedure and rise in per capita healthcare expenditure is anticipated to drive the growth of the market in the region.

Baxter International, Inc., Abbott Laboratories, Inc., Hikima Pharmaceuticals Plc, Halocarbon Products Corp., Piramal Group, AbbVie Inc., Troikaa Pharmaceuticals Ltd., Maruishi Pharmaceuticals Co. Ltd., Neon Laboratories Ltd., Novartis International AG (Sandoz) and so on are the key market players operating in the global inhalation anesthetics market. The major market players are actively adopting growth strategies such as mergers and acquisitions, partnerships, new product launch, investment in R&D activities among others to remain competitive in the global inhalation anesthetics market.

Research Methodology

The market study of the global inhalation anesthetics market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity in the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. Global Inhalation Anesthetics Market Research and Analysis by Application
2. Global Inhalation Anesthetics Market Research and Analysis by Product Type
3. Global Inhalation Anesthetics Market Research and Analysis by End-User

The Report Covers
  • Comprehensive research methodology of the global inhalation anesthetics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global inhalation anesthetics market.
  • Insights about market determinants which are stimulating the global inhalation anesthetics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Baxter International, Inc.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Halocarbon Products Corp.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Abbott Laboratories, Inc.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Piramal Group
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. AbbVie Inc.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities
5. Market Segmentation
5.1. Global Inhalation Anesthetics Market by Product Type
5.1.1. Sevoflurane
5.1.2. Isoflurane
5.1.3. Desflurane
5.1.4. Nitrous Oxide
5.1.5. Other
5.2. Global Inhalation Anesthetics Market by Application
5.2.1. Induction
5.2.2. Maintenance
5.3. Global Inhalation Anesthetics Market by End-User
5.3.1. Hospitals
5.3.2. Ambulatory Surgical Centers
5.3.3. Other End-Users
6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. AbbVie, Inc.
7.3. Baxter International, Inc.
7.4. Eisai Co., Ltd.
7.5. Fresenius Kabi AG
7.6. Halocarbon Products Corp.
7.7. Jiangsu Hengrui Medicine Co. Ltd.
7.8. LGM Pharma
7.9. Maruishi Pharmaceuticals Co. Ltd.
7.10. Merck KGaA
7.11. Neon Laboratories, Ltd.
7.12. Novartis International AG (Sandoz)
7.13. Piramal Group
7.14. Troikaa Pharmaceuticals, Ltd.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • AbbVie, Inc.
  • Baxter International, Inc.
  • Eisai Co., Ltd.
  • Fresenius Kabi AG
  • Halocarbon Products Corp.
  • Jiangsu Hengrui Medicine Co. Ltd.
  • LGM Pharma
  • Maruishi Pharmaceuticals Co. Ltd.
  • Merck KGaA
  • Neon Laboratories, Ltd.
  • Novartis International AG (Sandoz)
  • Piramal Group
  • Troikaa Pharmaceuticals, Ltd.